Cutaneous Oncology, An Issue of Hematology/Oncology Clinics of North America
- 1 Edición, Volumen 38-5 - 5 de septiembre de 2024
- Última edición
- Editor: David E. Fisher
- Idioma: Inglés
In this issue of Hematology/Oncology Clinics, guest editor Dr. David E. Fisher brings his considerable expertise to the topic of Cutaneous Oncology. Top experts first provide infor… Leer más
Descripción
Descripción
In this issue of Hematology/Oncology Clinics, guest editor Dr. David E. Fisher brings his considerable expertise to the topic of Cutaneous Oncology. Top experts first provide information on skin structure, function, and immunology, then offer overviews of the therapeutic state of the art for both melanoma and non-melanoma skin cancers. Discussions focus on unique clinical challenges and biological breakthroughs which have come to light in recent studies of cutaneous malignancies.
Puntos claves
Puntos claves
- Contains 16 relevant, practice-oriented topics including high risk non-melanoma skin cancers; progress in immune checkpoints for melanoma therapy; targeted therapy innovations for melanoma; advances in vaccines for melanoma; microbiome and immunotherapy; Merkel cell carcinoma; and more
- Provides in-depth clinical reviews on cutaneous oncology, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
De interès para
De interès para
Oncology, hematology
Índice
Índice
1. Epidemiology and Screening for Melanoma
2. Cutaneous Imaging Techniques
3. Unraveling the Functional Heterogeneity of Human Skin at Single-Cell Resolution
4. Nevi and Melanoma
5. Advances in Adjuvant and Neoadjuvant Therapy for Melanoma
6. Targeted Therapy Innovations for Melanoma
7. Progress in Immune Checkpoint Inhibitor for Melanoma Therapy
8. Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity
9. Melanoma Brain Metastasis: Biology and Therapeutic Advances
10. Advances in Vaccines for Melanoma
11. Microbiome and Immunotherapy for Melanoma: Are We Ready for Clinical Application?
12. High-Risk Non-Melanoma Skin Cancers: Biological and Therapeutic Advances
13. Cutaneous T-cell Lymphoma
14. Cutaneous B-Cell Lymphomas
15. Merkel Cell Carcinoma
2. Cutaneous Imaging Techniques
3. Unraveling the Functional Heterogeneity of Human Skin at Single-Cell Resolution
4. Nevi and Melanoma
5. Advances in Adjuvant and Neoadjuvant Therapy for Melanoma
6. Targeted Therapy Innovations for Melanoma
7. Progress in Immune Checkpoint Inhibitor for Melanoma Therapy
8. Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity
9. Melanoma Brain Metastasis: Biology and Therapeutic Advances
10. Advances in Vaccines for Melanoma
11. Microbiome and Immunotherapy for Melanoma: Are We Ready for Clinical Application?
12. High-Risk Non-Melanoma Skin Cancers: Biological and Therapeutic Advances
13. Cutaneous T-cell Lymphoma
14. Cutaneous B-Cell Lymphomas
15. Merkel Cell Carcinoma
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Volumen: 38-5
- Publicado: 5 de septiembre de 2024
- Idioma: Inglés
Sobre el editor
Sobre el editor
David E. Fisher
Editor
Afiliaciones y experiencia
Edward Wigglesworth Professor and Chairman, Department of Dermatology, Massachusetts General Hospital, Boston, USA; Director, Melanoma Program, MGH Cancer Center; Director, Cutaneous Biology Research Center, Harvard Medical School, Boston, USA